Medical Biomimetics Market will expand at 5.5% CAGR to surpass USD 34 bn by 2024: Global Market Insights, Inc.

The U.S. medical biomimetics market dominated North America industry with over 85% market share in 2017 and is expected to achieve lucrative growth in coming years owing to growing burden of chronic diseases coupled with aging population.


Sellbyville, Delaware, Dec. 18, 2018 (GLOBE NEWSWIRE) --

China medical biomimetics market is anticipated to witness 8.5% CAGR during the forecast period. Growing geriatric population base in the country coupled with rising incidences of cardiovascular diseases should drive Chinese industry. Rising disposable income, growing research activities for advancing biomimetic technology should positively impact industry growth.

Global medical biomimetics market will surpass USD 34 billion by 2024; according to a new research report by Global Market Insights, Inc. Increasing geriatric population should act as high impact rendering factor for medical biomimetics market. Increasing rate of organ transplantation has accelerated demand for prosthesis and implants. According to U.S. government’s data, around 34,770 transplants were conducted in the country in 2017.

Growing adoption of biomimetic technology for organ regeneration coupled with increasing research activity pertaining to application of biomimetics in healthcare should drive medical biomimetics industry. High rate of organ failure among elderly population, should substantially increase demand for biomimetics in coming future.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/767

Several applications of biomimetics in medical fields including dentistry, orthopedics, cardiology, ophthalmology and others should positively impact market size growth. Moreover, significant progress of tissue engineering, nanomedicine and several medical fields utilizing biomimetics should escalate business growth. However, stringent regulations will restrain industry growth to certain extent during the forecast period.

Cardiovascular product segment dominated the industry in 2017 and is anticipated to grow at 5.9% during the forecast timeframe. Increasing incidences of cardiovascular disorders due to growing adoption of sedentary lifestyle and unhealthy diet will act as primary driver for segment growth. Furthermore, technological advancements and increasing R&D activities such as development of advanced biomimetic heart that can be used as cardiovascular research instrument should positively impact industry growth.

Browse key industry insights spread across 120 pages with 188 market data tables & 9 figures & charts from the report, “Medical Biomimetics Market” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/medical-biomimetics-market

Drug delivery application segment is estimated to witness 6.3% CAGR during the analysis period owing to growing adoption of three-dimensional (3D) biomimetic models by pharmaceutical industry for controlled drug delivery. Advanced engineering technologies and appropriate biomaterials have enabled drug delivery in rate-adjusted way thereby fueling segmental growth. 

U.S. medical biomimetics market dominated North America region in 2017 and is estimated to reach over 15.1 billion by 2024. Increasing number of people suffering from chronic conditions such as cardiac disorder, rising rate of organ transplantation and presence of organization such as 3B’s Research Group that has collaborated with universities to advance research regarding biomaterial and development of biomimetic products will drive U.S. medical biomimetics market.

Some of the notable players operating in medical biomimetics market are Biomimetics Technologies, Veryan Medical, BioHorizons IPH, Avinent, BioHorizons, Applied Biomimetic, and Abbott. Market players are investing heavily in developing advanced biomimetic products especially in drug discovery and nanomedicine. In August 2013, Abbott acquired IDEV Technologies, that expanded company’s product portfolio with addition of Supera stent, based on biomimetic principles.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/767

Browse Related Reports:

  • Medical Gas Equipment Market Size Forecast 2018 – 2024

Global Medical Gas Equipment Market exceeded USD 4.3 billion in 2017 and is expected to witness more than 7.6% CAGR from 2018 to 2024 as rising prevalence of pulmonary diseases will propel the industry demand.

https://www.gminsights.com/industry-analysis/medical-gas-equipment-market

  • Geriatric Care Services Market Size Outlook 2018 – 2024

Geriatric Care Services Market crossed USD 842.0 billion in 2017 and is expected to witness more than 8.5% CAGR from 2018 to 2024 as continuous rise in geriatric population is increasing the financial demands on our health care system will fuel the industry demand.    
https://www.gminsights.com/industry-analysis/geriatric-care-services-market-report

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


            

Coordonnées